Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	vesicle cargo loading	CTAGE9 CTAGE8 CTAGE15 CTAGE4	1.57e-06	36	49	4	GO:0035459
GeneOntologyCellularComponent	endoplasmic reticulum exit site	CTAGE9 CTAGE8 CTAGE15 CTAGE4	1.98e-06	42	45	4	GO:0070971
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	KRT14 CCDC66 RPGRIP1L AMOT CEP162 KIF21A KRT20 MACF1 NCKAP5	1.06e-04	899	45	9	GO:0099513
GeneOntologyCellularComponent	supramolecular fiber	KRT14 CCDC66 RPGRIP1L AMOT CEP162 SYNE1 KIF21A KRT20 MACF1 NCKAP5	1.64e-04	1179	45	10	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	KRT14 CCDC66 RPGRIP1L AMOT CEP162 SYNE1 KIF21A KRT20 MACF1 NCKAP5	1.73e-04	1187	45	10	GO:0099081
GeneOntologyCellularComponent	RSC-type complex	PBRM1 BRD7	4.67e-04	15	45	2	GO:0016586
GeneOntologyCellularComponent	microtubule	CCDC66 RPGRIP1L CEP162 KIF21A MACF1 NCKAP5	9.35e-04	533	45	6	GO:0005874
MousePheno	enlarged stomach	ANKRD20A4P ANKRD20A3P ANKRD20A8P ANKRD20A1	2.00e-06	33	39	4	MP:0003883
MousePheno	absent intracranial segment of vertebral artery	RPGRIP1L CIR1	2.27e-05	3	39	2	MP:0013914
Domain	DUF3496	ANKRD26 CCDC144A	1.34e-05	3	40	2	PF12001
Domain	DUF3496	ANKRD26 CCDC144A	1.34e-05	3	40	2	IPR021885
Domain	Prefoldin	KRT14 AMOT TRAIP KIF21A	1.67e-05	72	40	4	IPR009053
Domain	Ank_2	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	9.15e-05	215	40	5	PF12796
Domain	Ank	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	1.21e-04	228	40	5	PF00023
Domain	-	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	1.78e-04	248	40	5	1.25.40.20
Domain	ANK	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	1.89e-04	251	40	5	SM00248
Domain	ANK_REPEAT	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	1.96e-04	253	40	5	PS50088
Domain	Ankyrin_rpt-contain_dom	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	1.99e-04	254	40	5	IPR020683
Domain	ANK_REP_REGION	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	1.99e-04	254	40	5	PS50297
Domain	Ankyrin_rpt	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	2.30e-04	262	40	5	IPR002110
Domain	CH	LMO7 SYNE1 MACF1	3.63e-04	65	40	3	SM00033
Domain	CH	LMO7 SYNE1 MACF1	4.51e-04	70	40	3	PF00307
Domain	-	LMO7 SYNE1 MACF1	4.70e-04	71	40	3	1.10.418.10
Domain	CH	LMO7 SYNE1 MACF1	5.10e-04	73	40	3	PS50021
Domain	CH-domain	LMO7 SYNE1 MACF1	5.52e-04	75	40	3	IPR001715
Domain	Actinin_actin-bd_CS	SYNE1 MACF1	1.10e-03	23	40	2	IPR001589
Domain	ACTININ_2	SYNE1 MACF1	1.10e-03	23	40	2	PS00020
Domain	ACTININ_1	SYNE1 MACF1	1.10e-03	23	40	2	PS00019
Domain	Spectrin	SYNE1 MACF1	1.10e-03	23	40	2	PF00435
Domain	Spectrin_repeat	SYNE1 MACF1	1.75e-03	29	40	2	IPR002017
Domain	Spectrin/alpha-actinin	SYNE1 MACF1	2.13e-03	32	40	2	IPR018159
Domain	SPEC	SYNE1 MACF1	2.13e-03	32	40	2	SM00150
Domain	BROMODOMAIN_1	PBRM1 BRD7	2.84e-03	37	40	2	PS00633
Domain	Bromodomain	PBRM1 BRD7	2.99e-03	38	40	2	PF00439
Domain	ZF_RING_1	MKRN3 TRAIP RNF216 MNAT1	3.39e-03	291	40	4	PS00518
Domain	BROMODOMAIN_2	PBRM1 BRD7	3.48e-03	41	40	2	PS50014
Domain	BROMO	PBRM1 BRD7	3.65e-03	42	40	2	SM00297
Domain	Bromodomain	PBRM1 BRD7	3.65e-03	42	40	2	IPR001487
Domain	-	PBRM1 BRD7	3.65e-03	42	40	2	1.20.920.10
Domain	ZF_RING_2	MKRN3 TRAIP RNF216 MNAT1	3.69e-03	298	40	4	PS50089
Domain	Keratin_I	KRT14 KRT20	4.00e-03	44	40	2	IPR002957
Domain	Intermediate_filament_CS	KRT14 KRT20	8.04e-03	63	40	2	IPR018039
Pubmed	Expression of testicular germ cell genes identified by differential display analysis.	ANKRD20A4P ANKRD20A3P ANKRD20A8P ANKRD20A1	2.86e-10	8	51	4	12634303
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KRT14 LMO7 DTNA SYNE1 KIF21A CTAGE8 EIF4G1 ANKRD26 CCDC150 CTAGE15 KRT20 MACF1 DLG3 CTAGE4 ALG2	1.34e-09	1442	51	15	35575683
Pubmed	Cullin 1 (CUL1) Promotes Primary Ciliogenesis through the Induction of Ubiquitin-Proteasome-Dependent Dvl2 Degradation.	LRRIQ1 AKAP9 AMOT SYNE1 MACF1	2.98e-06	152	51	5	34299191
Pubmed	Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.	SYNE1 ANKRD26 MACF1	3.33e-06	20	51	3	21689717
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	PTK2B AKAP9 LMO7 EXPH5 AMOT CEP162 EIF4G1 ANKRD26 MACF1	4.01e-06	861	51	9	36931259
Pubmed	Expression of cytokeratin 7, 20, 14 in urothelial carcinoma and squamous cell carcinoma of the Egyprian urinary bladder cancer.	KRT14 KRT20	6.32e-06	3	51	2	25643514
Pubmed	Polybromo-associated BRG1-associated factor components BRD7 and BAF180 are critical regulators of p53 required for induction of replicative senescence.	PBRM1 BRD7	6.32e-06	3	51	2	20660729
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PBRM1 AKAP9 SYNE1 KIF21A CALCOCO1 BRD7 EIF4G1 MACF1 DLG3	9.87e-06	963	51	9	28671696
Pubmed	Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance.	CTAGE9 CTAGE8	1.26e-05	4	51	2	33718348
Pubmed	Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.	CTAGE9 CTAGE8	1.26e-05	4	51	2	12586826
Pubmed	Mea6 controls VLDL transport through the coordinated regulation of COPII assembly.	CTAGE9 CTAGE8	1.26e-05	4	51	2	27311593
Pubmed	MEA6 Deficiency Impairs Cerebellar Development and Motor Performance by Tethering Protein Trafficking.	CTAGE9 CTAGE8	1.26e-05	4	51	2	31244610
Pubmed	Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites.	CTAGE9 CTAGE8	1.26e-05	4	51	2	21807889
Pubmed	Interaction of the tyrosine kinase Pyk2 with the N-methyl-D-aspartate receptor complex via the Src homology 3 domains of PSD-95 and SAP102.	PTK2B DLG3	1.26e-05	4	51	2	12576483
Pubmed	Nesprin-1α-Dependent Microtubule Nucleation from the Nuclear Envelope via Akap450 Is Necessary for Nuclear Positioning in Muscle Cells.	AKAP9 SYNE1	1.26e-05	4	51	2	28966089
Pubmed	Specific phosphopeptide enrichment with immobilized titanium ion affinity chromatography adsorbent for phosphoproteome analysis.	CTAGE9 CTAGE8	2.10e-05	5	51	2	18630941
Pubmed	cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.	CTAGE9 CTAGE4	2.10e-05	5	51	2	12839582
Pubmed	Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry.	CTAGE9 CTAGE8	2.10e-05	5	51	2	19131326
Pubmed	Characterization and expression pattern of the novel MIA homolog TANGO.	CTAGE9 CTAGE8	2.10e-05	5	51	2	15183315
Pubmed	Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development.	CTAGE9 CTAGE8	2.10e-05	5	51	2	38439956
Pubmed	A tissue-specific atlas of mouse protein phosphorylation and expression.	CTAGE9 CTAGE8	2.10e-05	5	51	2	21183079
Pubmed	KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis.	KRT14 KRT20	2.10e-05	5	51	2	27320313
Pubmed	Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.	AKAP9 KIF21A MACF1	2.23e-05	37	51	3	27565344
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	PTK2B AKAP9 SYNE1 MACF1	2.97e-05	120	51	4	31413325
Pubmed	Identification and characterization of cDNAs encoding four novel proteins that interact with translin associated factor-X.	TSNAXIP1 AKAP9	3.15e-05	6	51	2	12036294
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	PTK2B KRT14 LMO7 AMOT SYNE1 CALCOCO1 EIF4G1 MACF1 DLG3 ALG2	3.69e-05	1431	51	10	37142655
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	DTNA AMOT CALCOCO1 MACF1 DLG3 ALG2	3.88e-05	430	51	6	32581705
Pubmed	cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice.	CTAGE9 CTAGE8	4.41e-05	7	51	2	29133483
Pubmed	CHD7 cooperates with PBAF to control multipotent neural crest formation.	PBRM1 BRD7	5.87e-05	8	51	2	20130577
Pubmed	Epidermolysis Bullosa Simplex	KRT14 EXPH5	5.87e-05	8	51	2	20301543
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	RPGRIP1L AKAP9 CEP162 ANKRD26	6.39e-05	146	51	4	21399614
Pubmed	Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer.	PBRM1 BRD7	7.54e-05	9	51	2	30355451
Pubmed	Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.	CTAGE9 CTAGE8	7.54e-05	9	51	2	18342301
Pubmed	A human MAP kinase interactome.	KRT14 EXPH5 SYNE1 KRT20 MACF1 NCKAP5	7.63e-05	486	51	6	20936779
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	AKAP9 DTNA AMOT SYNE1 ANKRD26 MACF1	8.63e-05	497	51	6	23414517
Pubmed	The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development.	KRT14 AKAP9 MACF1	9.11e-05	59	51	3	26371508
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	MKRN3 LMO7 SYNE1 KIF21A EIF4G1 MACF1 RNF216 NCKAP5 MNAT1	9.36e-05	1285	51	9	35914814
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NCAPD3 RNMT LMO7 AMOT CEP162 KIF21A	1.21e-04	529	51	6	14621295
Pubmed	Arid1a regulates bladder urothelium formation and maintenance.	KRT14 KRT20	1.38e-04	12	51	2	35283102
Pubmed	Identification of potential bladder progenitor cells in the trigone.	KRT14 KRT20	1.38e-04	12	51	2	24992712
Pubmed	Creation of bladder assembloids mimicking tissue regeneration and cancer.	KRT14 KRT20	1.38e-04	12	51	2	33328632
Pubmed	Embryonic maturation of epidermal Merkel cells is controlled by a redundant transcription factor network.	KRT14 KRT20	1.38e-04	12	51	2	25468937
Pubmed	Lhx3, a LIM domain transcription factor, is regulated by Pou4f3 in the auditory but not in the vestibular system.	CALB2 DLG3	1.38e-04	12	51	2	17331196
Pubmed	Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice.	CTAGE9 CTAGE8	1.63e-04	13	51	2	11839810
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	KRT14 LMO7 EIF4G1 MACF1	1.80e-04	191	51	4	33762435
Pubmed	Retinoic acid induces prostatic bud formation.	KRT14 CYP26A1	1.90e-04	14	51	2	18393306
Pubmed	SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion.	PTK2B ALG2	1.90e-04	14	51	2	12771190
Pubmed	Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis.	KRT14 KRT20	1.90e-04	14	51	2	19786578
Pubmed	DNA sequence and analysis of human chromosome 9.	ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1 ALG2	2.08e-04	370	51	5	15164053
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KRT14 RPGRIP1L LMO7 DTNA ANKRD26 MACF1	2.15e-04	588	51	6	38580884
Pubmed	PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes.	PBRM1 BRD7	2.19e-04	15	51	2	15985610
Pubmed	cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development.	CTAGE9 CTAGE8	2.19e-04	15	51	2	30224460
Pubmed	Dissecting the Roles of Polycomb Repressive Complex 2 Subunits in the Control of Skin Development.	KRT14 KRT20	2.50e-04	16	51	2	26994968
Pubmed	Epithelial expression of Gata4 and Sox2 regulates specification of the squamous-columnar junction via MAPK/ERK signaling in mice.	KRT14 SYNE1	2.50e-04	16	51	2	33495473
Pubmed	RPGRIP1L is required for stabilizing epidermal keratinocyte adhesion through regulating desmoglein endocytosis.	KRT14 RPGRIP1L	2.50e-04	16	51	2	30689641
Pubmed	Proteomic analysis of NMDA receptor-adhesion protein signaling complexes.	PTK2B AKAP9 DLG3	2.79e-04	86	51	3	10862698
Pubmed	The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes.	PBRM1 BRD7	2.83e-04	17	51	2	11078522
Pubmed	The ciliopathy gene Rpgrip1l is essential for hair follicle development.	KRT14 RPGRIP1L	2.83e-04	17	51	2	25398052
Pubmed	FGF signalling controls the specification of hair placode-derived SOX9 positive progenitors to Merkel cells.	KRT14 KRT20	3.18e-04	18	51	2	29899403
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	LMO7 AMOT SYNE1 MACF1	3.36e-04	225	51	4	12168954
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CCDC66 PBRM1 AMOT CEP162 ANKRD26 MNAT1	3.52e-04	645	51	6	25281560
Pubmed	Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes.	PBRM1 BRD7	3.55e-04	19	51	2	12110891
Pubmed	Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins.	DTNA DLG3	3.55e-04	19	51	2	15024025
Pubmed	BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells.	PBRM1 BRD7	3.55e-04	19	51	2	18809673
Pubmed	Requirement for PBAF in transcriptional repression and repair at DNA breaks in actively transcribed regions of chromatin.	PBRM1 BRD7	3.55e-04	19	51	2	25066234
Pubmed	Role of the Pbrm1 subunit and the PBAF complex in Schwann cell development.	PBRM1 BRD7	3.55e-04	19	51	2	35173232
Pubmed	Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix.	PBRM1 BRD7	3.94e-04	20	51	2	9128241
Pubmed	The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex.	TRAIP MNAT1	4.35e-04	21	51	2	25590999
Pubmed	Sox2 modulates the function of two distinct cell lineages in mouse skin.	KRT14 KRT20	4.35e-04	21	51	2	23948231
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	AKAP9 SYNE1 MACF1	4.47e-04	101	51	3	9872452
Pubmed	The DNA sequence of human chromosome 7.	CTAGE9 AKAP9 CTAGE8 RNF216 CTAGE4	4.66e-04	441	51	5	12853948
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYNE1 MACF1 DLG3	4.74e-04	103	51	3	10574462
Pubmed	Pparg promotes differentiation and regulates mitochondrial gene expression in bladder epithelial cells.	KRT14 KRT20	4.78e-04	22	51	2	31597917
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	AKAP9 LMO7 AMOT CEP162 ANKRD26	4.90e-04	446	51	5	24255178
Pubmed	Systematic analysis of dimeric E3-RING interactions reveals increased combinatorial complexity in human ubiquitination networks.	MKRN3 TRAIP MNAT1	5.01e-04	105	51	3	22493164
Pubmed	Diversity and specialization of mammalian SWI/SNF complexes.	PBRM1 BRD7	5.23e-04	23	51	2	8804307
Pubmed	Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium.	KRT14 KRT20	5.70e-04	24	51	2	21803035
Pubmed	The SWI/SNF chromatin-remodeling factor stimulates repair by human excision nuclease in the mononucleosome core particle.	PBRM1 BRD7	5.70e-04	24	51	2	12215535
Pubmed	SWI/SNF chromatin remodeling and cancer.	PBRM1 BRD7	5.70e-04	24	51	2	11790558
Pubmed	Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.	PBRM1 BRD7	5.70e-04	24	51	2	10078207
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	EXPH5 AMOT ANKRD26 MACF1	6.04e-04	263	51	4	34702444
Pubmed	Cloning and characterization of three human cDNAs encoding mRNA (guanine-7-)-methyltransferase, an mRNA cap methylase.	RNMT MNAT1	6.19e-04	25	51	2	9790902
Pubmed	Isolation and characterization of a human cDNA for mRNA 5'-capping enzyme.	RNMT MNAT1	6.19e-04	25	51	2	9512541
Pubmed	ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1.	KRT14 SYNE1 ANKRD26	6.21e-04	113	51	3	34474245
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NR2C2 PBRM1 RNMT BRD7	6.48e-04	268	51	4	33640491
Pubmed	Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.	PBRM1 BRD7	6.70e-04	26	51	2	10778858
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	KRT14 PBRM1 LMO7 AMOT SYNE1 EIF4G1 MACF1	7.03e-04	1024	51	7	24711643
Pubmed	The transcription factor c-Maf controls touch receptor development and function.	CALB2 KRT20	7.23e-04	27	51	2	22345400
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	PTK2B SYNE1 MACF1 DLG3	7.73e-04	281	51	4	28706196
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	PBRM1 RNMT MACF1 NCKAP5	7.73e-04	281	51	4	24163370
Pubmed	Eda-activated RelB recruits an SWI/SNF (BAF) chromatin-remodeling complex and initiates gene transcription in skin appendage formation.	KRT14 PBRM1	7.78e-04	28	51	2	30037996
Pubmed	REST repression of neuronal genes requires components of the hSWI.SNF complex.	PBRM1 BRD7	7.78e-04	28	51	2	12192000
Pubmed	An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency.	PBRM1 BRD7	8.35e-04	29	51	2	19279220
Pubmed	Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPalpha.	AKAP9 MACF1	8.35e-04	29	51	2	18239623
Pubmed	Stage- and subunit-specific functions of polycomb repressive complex 2 in bladder urothelial formation and regeneration.	KRT14 CYP26A1	8.35e-04	29	51	2	28049658
Pubmed	Mammalian SWI/SNF collaborates with a polycomb-associated protein to regulate male germline transcription in the mouse.	PBRM1 BRD7	8.93e-04	30	51	2	31043422
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	KRT14 RPGRIP1L AMOT CEP162 ANKRD26 DLG3	9.34e-04	777	51	6	35844135
Pubmed	Splicing Regulator p54nrb /Non-POU Domain-Containing Octamer-Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box-Dependent Interacting Protein 1 in Hepatocellular Carcinoma.	LMO7 KIF21A	1.02e-03	32	51	2	31815296
Pubmed	Polycomb-Mediated Repression and Sonic Hedgehog Signaling Interact to Regulate Merkel Cell Specification during Skin Development.	KRT14 KRT20	1.08e-03	33	51	2	27414999
Pubmed	The role of primary cilia in corpus callosum formation is mediated by production of the Gli3 repressor.	RPGRIP1L CALB2	1.08e-03	33	51	2	26071364
Interaction	MAPRE3 interactions	CCDC66 AKAP9 LMO7 CEP162 TRAIP KIF21A MACF1 NCKAP5	7.68e-08	230	49	8	int:MAPRE3
Interaction	DYNLL2 interactions	NR2C2 CCDC66 RPGRIP1L AKAP9 ANKRD20A4P AMOT ANKRD20A2P ANKRD20A1	2.15e-07	263	49	8	int:DYNLL2
Interaction	ANKRD20A4P interactions	ANKRD20A4P ANKRD20A2P ANKRD20A1	2.69e-07	6	49	3	int:ANKRD20A4P
Interaction	ANKRD20A2P interactions	ANKRD20A4P ANKRD20A2P ANKRD20A1	4.70e-07	7	49	3	int:ANKRD20A2P
Interaction	CTAGE1 interactions	CTAGE8 CTAGE15 CTAGE4	1.60e-06	10	49	3	int:CTAGE1
Interaction	PCNT interactions	RPGRIP1L AKAP9 AMOT CEP162 SYNE1 BRD7 MACF1	1.80e-06	241	49	7	int:PCNT
Interaction	ANKRD20A1 interactions	ANKRD20A4P ANKRD20A2P ANKRD20A1	2.20e-06	11	49	3	int:ANKRD20A1
Interaction	APC interactions	KRT14 RPGRIP1L EXPH5 AMOT SYNE1 MACF1 DLG3 NCKAP5	4.05e-06	389	49	8	int:APC
Interaction	KRT19 interactions	NR2C2 KRT14 AKAP9 AMOT CEP162 CALCOCO1 ANKRD26	5.07e-06	282	49	7	int:KRT19
Interaction	NDC80 interactions	CCDC66 RPGRIP1L AKAP9 AMOT CEP162 CALCOCO1 ANKRD26	9.80e-06	312	49	7	int:NDC80
Interaction	TCHP interactions	MKRN3 KRT14 RPGRIP1L AMOT CEP162	1.63e-05	131	49	5	int:TCHP
Interaction	DYNLL1 interactions	NR2C2 RPGRIP1L AKAP9 ANKRD20A4P AMOT KIF21A EIF4G1 ANKRD20A2P	2.88e-05	510	49	8	int:DYNLL1
Interaction	OR8B8 interactions	PBRM1 BRD7	3.46e-05	4	49	2	int:OR8B8
Interaction	SFN interactions	MKRN3 AKAP9 LMO7 EXPH5 AMOT CEP162 EIF4G1 ANKRD26 MACF1	3.78e-05	692	49	9	int:SFN
Interaction	CEP135 interactions	CCDC66 RPGRIP1L AKAP9 LMO7 CEP162 ANKRD26	4.92e-05	272	49	6	int:CEP135
Interaction	DVL2 interactions	NR2C2 RPGRIP1L LRRIQ1 AKAP9 AMOT SYNE1 MACF1 DLG3	5.38e-05	557	49	8	int:DVL2
Interaction	CEP128 interactions	CCDC66 RPGRIP1L LMO7 AMOT CEP162 ANKRD26	8.00e-05	297	49	6	int:CEP128
Interaction	KRT8 interactions	KRT14 RPGRIP1L AKAP9 DTNA CEP162 ANKRD26 KRT20	8.90e-05	441	49	7	int:KRT8
Interaction	LXN interactions	NR2C2 CEP162 TRAIP	1.16e-04	39	49	3	int:LXN
Interaction	H1-5 interactions	NR2C2 PBRM1 LMO7 DTNA SYNE1 ANKRD26 CCDC168	1.20e-04	463	49	7	int:H1-5
Interaction	MIA2 interactions	MKRN3 CTAGE8 CTAGE15 CTAGE4	1.63e-04	113	49	4	int:MIA2
Interaction	GTF2H2 interactions	NR2C2 ARHGAP25 MNAT1	2.03e-04	47	49	3	int:GTF2H2
Interaction	KRT24 interactions	AARD AMOT KRT20	3.07e-04	54	49	3	int:KRT24
Interaction	TNIK interactions	AKAP9 SYNE1 CALCOCO1 BRD7 MACF1 DLG3	3.09e-04	381	49	6	int:TNIK
Cytoband	7q35	CTAGE8 CTAGE15 CTAGE4	3.25e-05	55	51	3	7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr7q35	CTAGE8 CTAGE15 CTAGE4	5.62e-05	66	51	3	chr7q35
Cytoband	9p12	ANKRD20A2P ANKRD20A3P	4.82e-04	29	51	2	9p12
GeneFamily	CTAGE family	CTAGE9 CTAGE8 CTAGE15 CTAGE4	9.52e-09	15	31	4	907
GeneFamily	Ankyrin repeat domain containing	ANKRD20A4P ANKRD26 ANKRD20A2P ANKRD20A3P ANKRD20A1	5.27e-05	242	31	5	403
GeneFamily	Keratins, type I	KRT14 KRT20	1.05e-03	28	31	2	608
GeneFamily	Ring finger proteins	MKRN3 TRAIP RNF216 MNAT1	1.19e-03	275	31	4	58
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	RPGRIP1L AKAP9 DLG3	3.61e-03	181	31	3	694
Coexpression	TRAVAGLINI_LUNG_CILIATED_CELL	TSNAXIP1 CCDC66 RPGRIP1L LRRIQ1 AKAP9 CEP162 SYNE1 KIF21A ANKRD26 CIR1 MNAT1	6.48e-06	1093	51	11	M41649
Coexpression	GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS	TSNAXIP1 RPGRIP1L LRRIQ1 DTNA CEP162 SYNE1 MACF1	2.87e-05	459	51	7	M39136
ToppCell	COPD-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A1	6.66e-08	184	51	6	42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94
ToppCell	IPF-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A1	7.10e-08	186	51	6	962c2dada19185628ead77c32fcb07fa95114247
ToppCell	IPF-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A1	7.57e-08	188	51	6	47bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A1	7.57e-08	188	51	6	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	COPD-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A1	8.31e-08	191	51	6	3480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCell	COPD-Myeloid-cDC1\|COPD / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P NCKAP5 ANKRD20A3P ANKRD20A8P ANKRD20A1	8.57e-08	192	51	6	bd3d00b094d92463b06023361a71240851a542b8
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 RPGRIP1L LRRIQ1 AKAP9 SYNE1 ANKRD26	9.98e-08	197	51	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	Control-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A1	2.18e-06	184	51	5	c6affa0b12510363258f65e46bf2d47bf4a8e75f
ToppCell	Control-Myeloid-cDC1\|Control / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A1	2.30e-06	186	51	5	b05c394aa3573ba855abc3066739ca193883b0c3
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	LMO7 DTNA EXPH5 SYNE1 ANKRD20A2P	2.43e-06	188	51	5	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	LMO7 DTNA KIF21A RNF216 NCKAP5	2.76e-06	193	51	5	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNMT AKAP9 SYNE1 MACF1 CTAGE4	3.05e-06	197	51	5	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	SYNE1 TRAIP MACF1 DLG3 ARHGAP25	3.13e-06	198	51	5	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	LRRIQ1 AKAP9 EXPH5 CEP162 ANKRD26	3.13e-06	198	51	5	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	LRRIQ1 AKAP9 CEP162 KIF21A ANKRD26	3.21e-06	199	51	5	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	ASK454-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	AKAP9 LMO7 EXPH5 NCKAP5	2.56e-05	149	51	4	078792d5272f1881757dc47daa96e87449cf5d34
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSNAXIP1 CALB2 LRRIQ1 CCDC150	2.69e-05	151	51	4	633ed52dd3b4cf1e87432cf0a1ca187d7b204e83
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TSNAXIP1 CALB2 LRRIQ1 CCDC150	2.69e-05	151	51	4	e335dad89e0a44cdd302b9653154ba5d1ee5fe1a
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	LMO7 DTNA EXPH5 SYNE1	3.14e-05	157	51	4	84f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell	Control\|World / group, cell type (main and fine annotations)	LMO7 EXPH5 SYNE1 NCKAP5	4.09e-05	168	51	4	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ANKRD20A4P AARD ANKRD20A2P ANKRD20A1	4.28e-05	170	51	4	81341bf4fe090af70b2091b6b2579ed08d76e22d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	AKAP9 SYNE1 MACF1 CCDC144A	4.38e-05	171	51	4	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANKRD20A4P LMO7 ARHGAP25 ANKRD20A1	4.69e-05	174	51	4	99eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TSNAXIP1 CCDC150 CCDC168	4.95e-05	62	51	3	91c49ae176d2a418a58398e9d5e55c77187cc2fb
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Crim1_(Neuron.Gad1Gad2.Cplx3-Crim1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TSNAXIP1 CCDC150 CCDC168	4.95e-05	62	51	3	3275775572a65460b6248ee72b4c85e4d4dee424
ToppCell	wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PTK2B ANKRD20A4P CALCOCO1 ANKRD20A1	5.58e-05	182	51	4	93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	LMO7 DTNA RNF216 NCKAP5	5.58e-05	182	51	4	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	Control-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1	6.07e-05	186	51	4	3de803dee3ef10eb85a2b47d3f93385214e5b0ff
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|World / Chamber and Cluster_Paper	LMO7 DTNA KIF21A NCKAP5	6.20e-05	187	51	4	78cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	LRRIQ1 LMO7 SYNE1 KIF21A	6.33e-05	188	51	4	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	ASK454-Epithelial-Type_1\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	LMO7 DTNA EXPH5 NCKAP5	6.33e-05	188	51	4	13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2
ToppCell	RV-04._Ventricular_Cardiomyocyte_I\|RV / Chamber and Cluster_Paper	LMO7 DTNA KIF21A NCKAP5	6.46e-05	189	51	4	9c1debd65c13d63fd4f3158917d621b44b714c26
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	ANKRD20A4P SYNE1 ANKRD20A2P NCKAP5	6.59e-05	190	51	4	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PTK2B DTNA KIF21A NCKAP5	6.59e-05	190	51	4	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	LMO7 DTNA KIF21A NCKAP5	6.73e-05	191	51	4	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD20A4P SYNE1 KIF21A MACF1	6.87e-05	192	51	4	58a7829b411b02b422ef75e2277a868969cc23e8
ToppCell	LV-04._Ventricular_Cardiomyocyte_I\|LV / Chamber and Cluster_Paper	LMO7 DTNA KIF21A NCKAP5	6.87e-05	192	51	4	ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD20A4P SYNE1 KIF21A MACF1	6.87e-05	192	51	4	ce867b6e78c1d8f30dff81bf572a78a897bc7625
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LRRIQ1 LMO7 EXPH5 KIF21A	6.87e-05	192	51	4	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AKAP9 SYNE1 MACF1 CTAGE4	7.01e-05	193	51	4	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	PND01\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LMO7 CALCOCO1 CIR1 MACF1	7.01e-05	193	51	4	c291345c11cfcbceacbdc001a5851f67478a2779
ToppCell	IPF-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	LMO7 EXPH5 SYNE1 NCKAP5	7.15e-05	194	51	4	777ce41c3f22c591e2d81120f189b834e53ffb4b
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	LMO7 DTNA KIF21A NCKAP5	7.15e-05	194	51	4	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	LMO7 DTNA KIF21A NCKAP5	7.15e-05	194	51	4	c3535f7cc0076653c72db582047cff053c322397
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LRRIQ1 LMO7 EXPH5 KIF21A	7.15e-05	194	51	4	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TSNAXIP1 RPGRIP1L LRRIQ1 SYNE1	7.15e-05	194	51	4	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	COVID-19-Heart-CM_1\|Heart / Disease (COVID-19 only), tissue and cell type	LMO7 DTNA KIF21A NCKAP5	7.29e-05	195	51	4	f1ef50331eda8f1239dba6ea970df4eaccf032f1
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LMO7 EXPH5 SYNE1 NCKAP5	7.29e-05	195	51	4	9406866f99555198a9be311fbd65751b70f35446
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LRRIQ1 LMO7 EXPH5 KIF21A	7.29e-05	195	51	4	ce1ba5911e8a6ddb07434acc37147c38e94245ff
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	LMO7 DTNA KIF21A NCKAP5	7.29e-05	195	51	4	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SYNE1 KIF21A MACF1 ARHGAP25	7.44e-05	196	51	4	af00c31612e4fe068e5fccae05368edba46bbd20
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	LRRIQ1 LMO7 SYNE1 MACF1	7.44e-05	196	51	4	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	PCW_10-12-Epithelial\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LRRIQ1 LMO7 EXPH5 KIF21A	7.44e-05	196	51	4	9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	LRRIQ1 LMO7 SYNE1 MACF1	7.44e-05	196	51	4	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	ANKRD20A4P ANKRD20A2P NCKAP5 ANKRD20A3P	7.58e-05	197	51	4	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SYNE1 KIF21A MACF1 ARHGAP25	7.58e-05	197	51	4	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRIQ1 AKAP9 SYNE1 KIF21A	7.58e-05	197	51	4	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	RNMT AKAP9 LMO7 KIF21A	7.58e-05	197	51	4	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRIQ1 AKAP9 SYNE1 KIF21A	7.58e-05	197	51	4	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRIQ1 AKAP9 SYNE1 KIF21A	7.58e-05	197	51	4	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	AKAP9 LMO7 KIF21A MNAT1	7.58e-05	197	51	4	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	Bronchial_Brush-Epithelial\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	LRRIQ1 AKAP9 LMO7 KIF21A	7.58e-05	197	51	4	272c7f4e582ef57564450540242b0db766b78328
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRIQ1 AKAP9 SYNE1 KIF21A	7.58e-05	197	51	4	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	SYNE1 KIF21A MACF1 ARHGAP25	7.58e-05	197	51	4	d4dfb3b561d0783cdbee4e8d27009ad81df695cb
ToppCell	mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC\|mLN / shred on region, Cell_type, and subtype	ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1	7.73e-05	198	51	4	da84c76afe835aeee39da04b63c03549218b5d91
ToppCell	Control_saline-Epithelial_alveolar-AT_1\|Control_saline / Treatment groups by lineage, cell group, cell type	AARD LMO7 EXPH5 KIF21A	7.73e-05	198	51	4	9b161285df7a4e51618f3517cfc5b8221ba55786
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-CD4+_CTL\|Int-URO / Disease, condition lineage and cell class	AARD SYNE1 KIF21A DLG3	7.73e-05	198	51	4	717735d755745439f97ba1b71785c73945dfa9c5
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	RNMT AKAP9 LMO7 KIF21A	7.73e-05	198	51	4	285f729140b1df029c24f6ca1d2438470ac51794
ToppCell	mLN-Dendritic_cell-Lymphoid_DC\|mLN / Region, Cell class and subclass	ANKRD20A4P ANKRD20A2P ANKRD20A3P ANKRD20A1	7.73e-05	198	51	4	3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	AARD LMO7 EXPH5 KIF21A	7.89e-05	199	51	4	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	LRRIQ1 AKAP9 LMO7 ANKRD26	7.89e-05	199	51	4	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RNMT AKAP9 LMO7 KIF21A	8.04e-05	200	51	4	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AKAP9 LMO7 EXPH5 KIF21A	8.04e-05	200	51	4	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AKAP9 LMO7 EXPH5 KIF21A	8.04e-05	200	51	4	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RNMT LMO7 EXPH5 KIF21A	8.04e-05	200	51	4	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AKAP9 LMO7 EXPH5 KIF21A	8.04e-05	200	51	4	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Bronchus_Control_(B.)-Epithelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	LRRIQ1 LMO7 EXPH5 KIF21A	8.04e-05	200	51	4	f5bc7d30aa03dd0f95eb64255bd1a2543be8d327
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNMT AKAP9 BRD7 MACF1	8.04e-05	200	51	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	AKAP9 SYNE1 KIF21A MACF1	8.04e-05	200	51	4	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Mixed_Serous_and_Endometrioid\|TCGA-Endometrium / Sample_Type by Project: Shred V9	ANKRD20A3P ANKRD20A8P CCDC144A	1.76e-04	95	51	3	39fdc7d3d12877f39a16ed460259a2b29a88867f
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	AKAP9 SYNE1 MACF1	3.60e-04	121	51	3	19333a660800b583fa27b495c1f7828e6636a257
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_immature_4\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TSNAXIP1 NDUFAF4 TRAIP	4.44e-04	130	51	3	169d88bffd7cd813a484d809defa638ceaca4bcb
ToppCell	AT2_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD20A4P ANKRD20A2P ANKRD20A3P	4.54e-04	131	51	3	ff4e618bd944f852bbd34438f740187aca82460f
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	MKRN3 NCKAP5 CCDC168	4.95e-04	135	51	3	3351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCell	3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	AKAP9 SYNE1 MACF1	4.95e-04	135	51	3	ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	AKAP9 CYP26A1 BRD7	5.28e-04	138	51	3	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PBRM1 RPGRIP1L NCKAP5	5.50e-04	140	51	3	af9efcbaeeae69fcdac4a15fa244728b65915564
ToppCell	severe_COVID-19-gd_T\|World / disease group, cell group and cell class (v2)	MKRN3 ANKRD20A2P ANKRD20A3P	5.62e-04	141	51	3	d2575900775ce6801364c2d4eed8d213f30fa0e0
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PTK2B CCDC168 CCDC144A	5.74e-04	142	51	3	f720f13b339589fa924a42e89393e5db0b26300b
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PTK2B LMO7 CYP26A1	5.97e-04	144	51	3	e2a2f260f5ebaaef46248d199c407a15ce9d024a
ToppCell	COVID-19_Moderate-multiplets\|COVID-19_Moderate / disease group, cell group and cell class	SYNE1 MACF1 NCKAP5	6.34e-04	147	51	3	baf15c773d7751bc6f64d4974a22738626f2b3ff
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_dendritic_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ANKRD20A4P NCKAP5 ANKRD20A3P	6.60e-04	149	51	3	71d72a6e7b128ee96161e08f6a0d77be925e73a1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 KIF21A MACF1	6.86e-04	151	51	3	b545823113a3450c5f841f7de48bf0937593544f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE1 KIF21A MACF1	6.86e-04	151	51	3	0cc2f4aec3dae4603fa831f22c40f897e68b34e2
ToppCell	COVID-19_Severe-multiplets\|COVID-19_Severe / disease group, cell group and cell class	SYNE1 NCKAP5 ANKRD20A1	6.99e-04	152	51	3	451745151322c2fcea22dbb3dba681e12634a510
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RPGRIP1L LRRIQ1 ANKRD26	7.68e-04	157	51	3	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DTNA SYNE1 CCDC168	7.82e-04	158	51	3	e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DTNA SYNE1 CCDC168	7.82e-04	158	51	3	d39e020c3e77eb9d3de600a171d22f94357061d4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SYNE1 ARHGAP25 CCDC168	7.96e-04	159	51	3	bf8ff9251bcb64b2b9d6dd93461aec97659686ec
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTK2B EXPH5 KRT20	7.96e-04	159	51	3	a082e770fa757c4a1d3ed13d53f83297e36faf05
Drug	Moxonidine [75438-57-2]; Down 200; 16.6uM; MCF7; HT_HG-U133A	RNMT DTNA CEP162 TRAIP CIR1 RNF216	3.74e-06	199	48	6	7343_DN
Drug	N-methyl-5H-purin-6-amine	RNMT DTNA TRDMT1	7.02e-06	18	48	3	CID000408161
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA	NR2C2 AKAP9 DTNA CALCOCO1 CIR1	4.22e-05	184	48	5	1007_UP
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	AKAP9 CEP162 CALCOCO1 ANKRD26 CIR1	4.44e-05	186	48	5	1664_UP
Drug	wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A	RNMT EXPH5 CEP162 CYP26A1 CALCOCO1	4.79e-05	189	48	5	7002_UP
Drug	Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; MCF7; HT_HG-U133A	PTK2B RPGRIP1L RNMT DTNA ANKRD26	4.79e-05	189	48	5	5413_UP
Drug	Bepridil hydrochloride [74764-40-2]; Down 200; 10uM; MCF7; HT_HG-U133A	AKAP9 DTNA TRAIP CYP26A1 DLG3	5.42e-05	194	48	5	5674_DN
Drug	N6-methyladenine	RNMT DTNA TRDMT1	5.49e-05	35	48	3	CID000067955
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A	RNMT TRAIP CYP26A1 ANKRD26 CIR1	5.83e-05	197	48	5	7347_DN
Drug	Procainamide hydrochloride [614-39-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A	RPGRIP1L DTNA CEP162 CYP26A1 DLG3	5.83e-05	197	48	5	5663_DN
Drug	Lincomycin hydrochloride [859-18-7]; Down 200; 9uM; MCF7; HT_HG-U133A	DTNA EXPH5 TRAIP ANKRD26 RNF216	5.98e-05	198	48	5	5992_DN
Drug	Adrenosterone [382-45-6]; Down 200; 13.4uM; HL60; HT_HG-U133A	MKRN3 PTK2B RNMT EXPH5 ANKRD26	5.98e-05	198	48	5	3107_DN
Drug	Chlormezanone [80-77-3]; Down 200; 14.6uM; PC3; HT_HG-U133A	CEP162 ANKRD26 CIR1 KRT20 TRDMT1	5.98e-05	198	48	5	4636_DN
Drug	Isometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A	RPGRIP1L CEP162 TRAIP CYP26A1 ANKRD26	5.98e-05	198	48	5	6524_DN
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	RPGRIP1L RNMT DTNA TRAIP CYP26A1	5.98e-05	198	48	5	4979_DN
Drug	Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	RPGRIP1L RNMT CYP26A1 CIR1 DLG3	5.98e-05	198	48	5	4705_DN
Drug	MObetaDG	PTK2B KRT20	6.49e-05	6	48	2	CID000124815
Drug	3-nitro-4-hydroxyphenylacetic acid	NR2C2 RNMT AKAP9 DTNA	9.14e-05	112	48	4	CID000447364
Disease	Epidermolysis Bullosa	KRT14 EXPH5	1.18e-05	4	42	2	C0014527
Disease	Epidermolysis Bullosa Simplex	KRT14 EXPH5	1.97e-05	5	42	2	C0079298
Disease	cerebellar ataxia (is_implicated_in)	RPGRIP1L SYNE1	1.97e-05	5	42	2	DOID:0050753 (is_implicated_in)
Disease	epidermolysis bullosa simplex (is_implicated_in)	KRT14 EXPH5	4.13e-05	7	42	2	DOID:4644 (is_implicated_in)
Disease	Colorectal Carcinoma	MKRN3 AKAP9 LMO7 SYNE1 EIF4G1 KRT20 DLG3	5.47e-05	702	42	7	C0009402

Protein segments in the cluster

Peptide	Gene	Start	Entry
MKNDNLEKENKYLKD	ANKRD20A1	531	Q5TYW2
NMKVQQLKKEYELEI	AARD	126	Q4LEZ3
KVYEMEQDKKVENSN	AKAP9	306	Q99996
KQVYVDKVEKMQQAL	AMOT	596	Q4VCS5
MKNDNLEKENKYLKD	ANKRD20A8P	531	Q5CZ79
QQKLKIMTEFYQENE	CTAGE4	381	Q8IX94
QQKLKIMTEFYQENE	CTAGE8	381	P0CG41
QQKLKIMTEFYQENE	CTAGE9	381	A4FU28
QQKLKIMTEFYQENE	CTAGE15	381	A4D2H0
MKEKIKNNDYQSIEE	BRD7	181	Q9NPI1
MKNDNLEKENKYLKD	ANKRD20A4P	531	Q4UJ75
ENYLSKMQQELEKNI	ANKRD26	1646	Q9UPS8
KFQEKAQMELQDYVQ	NR2C2	516	P49116
MKNDNLEKENKYLKD	ANKRD20A2P	531	Q5SQ80
KIQQKLKMEEYDDVN	PBRM1	96	Q86U86
KMEIYQKENKDVIQK	MNAT1	121	P51948
KMENLQQDYELKVEQ	RPGRIP1L	536	Q68CZ1
MEQQNQEYKILLDVK	KRT14	391	P02533
QYAKDQKELKEKMQL	PIGBOS1	31	A0A0B4J2F0
EEKYQKAENMYAQIK	MACF1	1986	O94854
NEMKEFKVEVYQQQI	MACF1	2281	O94854
YEEMQKIKSQLKEQD	LMO7	721	Q8WWI1
QKENFQEYTEKEGKM	EXPH5	1181	Q8NEV8
YEVMAQKNLQEAKEQ	KRT20	246	P35900
KQEQDKMNDELYKEE	LRRIQ1	226	Q96JM4
KYQKAENMYAQIKEE	MACF1	5861	Q9UPN3
MKNDNLEKENKYLKD	ANKRD20A3P	531	Q5VUR7
KELKQMELIKDQYQK	CCDC150	921	Q8NCX0
MELIKDQYQKKNYEQ	CCDC150	926	Q8NCX0
EMQKQYEEDILKQKQ	CCDC66	506	A2RUB6
KMKIQYEQRLEQQEQ	CEP162	996	Q5TB80
EQANKIYDKAMKLEQ	DLG3	761	Q92796
DQYFNQMEKIIKEKK	EIF4G1	956	Q04637
LEFYEEKIKNNENKM	RNMT	396	O43148
ELQMEEYLKQKLQDE	DTNA	721	Q9Y4J8
DLYEKNKKEMNIQQL	CALB2	226	P22676
QDNKLDMEILEQLKY	CYP26A1	341	O43174
QKAKDYMQQKEDDEV	CCDC168	4146	Q8NDH2
SEVQKAKDYMQQKEE	CCDC168	4326	Q8NDH2
QILDKQQKQMVEDYQ	PTK2B	806	Q14289
QCQKKETEQMYQIEQ	CCDC144A	1011	A2RUR9
KEQLQEEKQELLEYM	CALCOCO1	486	Q9P1Z2
KYAMDVENKIQEKNV	TRDMT1	196	O14717
RQNIEKMAEEQKEKY	SYNE1	5371	Q8NF91
QKKEETVNIMVYQEK	NCKAP5	131	O14513
EKIMQEYQLEQKDVN	NDUFAF4	136	Q9P032
QQEQEFYEQKIKEMA	RNF216	476	Q9NWF9
ENVEHYQELKKMVQQ	ALG2	276	Q9H553
KISYDKKKQEELMQQ	CIR1	31	Q86X95
KKKQEELMQQYLKEQ	CIR1	36	Q86X95
MKKYQEQLVQEQELA	NCAPD3	1256	P42695
EEEKQKLIQQYKEAM	MKRN3	381	Q13064
QYEKQLKKLQQDVME	KIF21A	751	Q7Z4S6
TQKQMYEEQIKNLEK	ARHGAP25	566	P42331
MDEKDEYLQQLKQEL	TSNAXIP1	561	Q2TAA8
KKQMKYLEQQQDETK	TRAIP	136	Q9BWF2